|
1
|
Klein S, Wadden T and Sugerman HJ: AGA
technical review on obesity. Gastroenterology. 123:882–932. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lorincz AM and Sukumar S: Molecular links
between obesity and breast cancer. Endocr Relat Cancer. 13:279–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wolk A, Gridley G, Svensson M, Nyren O,
McLaughlin JK, Fraumeni JF and Adam HO: A prospective study of
obesity and cancer risk (Sweden). Cancer Causes Control. 12:13–21.
2001. View Article : Google Scholar
|
|
4
|
Chlebowski RT, Aiello E and McTiernan A:
Weight loss in breast cancer patient management. J Clin Oncol.
20:1128–1143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daling JR, Malone KE, Doody DR, Johnson
LG, Gralow JR and Porter PL: Relation of body mass index to tumor
markers and survival among young women with invasive ductal breast
carcinoma. Cancer. 92:720–729. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Belfiore A and Frasca F: IGF and insulin
receptor signaling in breast cancer. J Mammary Gland Biol
Neoplasia. 13:381–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cold S, Hansen S, Overvad K and Rose C: A
woman’s build and the risk of breast cancer. Eur J Cancer.
34:1163–1174. 1998.
|
|
8
|
Pischon T, Nothlings U and Boeing H:
Obesity and cancer. Proc Nutr Soc. 67:128–145. 2008. View Article : Google Scholar
|
|
9
|
Fantuzzi G: Adipose tissue, adipokines,
and inflammation. J Allergy Clin Immunol. 115:911–919. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tilg H and Moschen AR: Adipocytokines:
mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–783. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perrier S, Caldefie-Chezet F and Vasson
MP: IL-1 family in breast cancer: potential interplay with leptin
and other adipocytokines. FEBS Lett. 583:259–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rose DP, Komninou D and Stephenson GD:
Obesity, adipocytokines, and insulin resistance in breast cancer.
Obes Rev. 5:153–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schaffler A, Scholmerich J and Buechler C:
Mechanisms of disease: adipokines and breast cancer - endocrine and
paracrine mechanisms that connect adiposity and breast cancer. Nat
Clin Pract Endocrinol Metab. 3:345–354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vona-Davis L, Howard-McNatt M and Rose DP:
Adiposity, type 2 diabetes and the metabolic syndrome in breast
cancer. Obes Rev. 8:395–408. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jarde T, Caldefie-Chezet F, Damez M,
Mishellany F, Perrone D, Penault-Llorca F, Guillot J and Vasson MP:
Adiponectin and leptin expression in primary ductal breast cancer
and in adjacent healthy epithelial and myoepithelial tissue.
Histopathology. 53:484–487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jarde T, Caldefie-Chezet F,
Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F and
Vasson MP: Involvement of adiponectin and leptin in breast cancer:
clinical and in vitro studies. Endocr Relat Cancer. 16:1197–1210.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jarde T, Perrier S, Vasson MP and
Caldefie-Chezet F: Molecular mechanisms of leptin and adiponectin
in breast cancer. Eur J Cancer. 47:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bing C, Bao Y, Jenkins J, Sanders P,
Manieri M, Cinti S, Tisdale MJ and Trayhurn P:
Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed
in adipocytes and is up-regulated in mice with cancer cachexia.
Proc Natl Acad Sci USA. 101:2500–2505. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marrades MP, Martinez JA and Moreno-Aliaga
MJ: ZAG, a lipid mobilizing adipokine, is downregulated in human
obesity. J Physiol Biochem. 64:61–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mracek T, Ding Q, Tzanavari T, Kos K,
Pinkney J, Wilding J, Trayhurn P and Bing C: The adipokine
zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass
expansion in obesity. Clin Endocrinol. 72:334–341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bundred NJ, Miller WR and Walker RA: An
immunohistochemical study of the tissue distribution of the breast
cyst fluid protein, zinc alpha 2 glycoprotein. Histopathology.
11:603–610. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diez-Itza I, Sanchez LM, Allende MT,
Vizoso F, Ruibal A and Lopez-Otin C: Zn-alpha 2-glycoprotein levels
in breast cancer cytosols and correlation with clinical,
histological and biochemical parameters. Eur J Cancer.
29A:1256–1260. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bundred NJ, Scott WN, Davies SJ, Miller WR
and Mansel RE: Zinc alpha-2 glycoprotein levels in serum and breast
fluids: a potential marker of apocrine activity. Eur J Cancer.
27:549–552. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sanchez LM, Vizoso F, Diez-Itza I and
Lopez-Otin C: Identification of the major protein components in
breast secretions from women with benign and malignant breast
diseases. Cancer Res. 52:95–100. 1992.PubMed/NCBI
|
|
25
|
Dubois V, Delort L, Mishellany F, Jarde T,
Billard H, Lequeux C, Damour O, Penault-Llorca F, Vasson MP and
Caldefie-Chezet F: Zinc-alpha2-glycoprotein: a new biomarker of
breast cancer? Anticancer Res. 30:2919–2925. 2010.PubMed/NCBI
|
|
26
|
Meyer N, Kim SS and Penn LZ: The
Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol.
16:275–287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prendergast GC: Mechanisms of apoptosis by
c-Myc. Oncogene. 18:2967–2987. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakamuro D, Eviner V, Elliott KJ, Showe L,
White E and Prendergast GC: c-Myc induces apoptosis in epithelial
cells by both p53-dependent and p53-independent mechanisms.
Oncogene. 11:2411–2418. 1995.PubMed/NCBI
|
|
29
|
Lee YJ, Galoforo SS, Berns CM, Tong WP,
Kim HR and Corry PM: Glucose deprivation-induced cytotoxicity in
drug resistant human breast carcinoma MCF-7/ADR cells: role of
c-myc and bcl-2 in apoptotic cell death. J Cell Sci. 110:681–686.
1997.PubMed/NCBI
|
|
30
|
He N, Brysk H, Tyring SK, Ohkubo I and
Brysk MM: Zinc-alpha(2)-glycoprotein hinders cell proliferation and
reduces cdc2 expression. J Cell Biochem Suppl. 36:162–169. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zapata JM, Krajewska M, Krajewski S, Huang
RP, Takayama S, Wang HG, Adamson E and Reed JC: Expression of
multiple apoptosis-regulatory genes in human breast cancer cell
lines and primary tumors. Breast Cancer Res Treat. 47:129–140.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iyengar P, Combs TP, Shah SJ, Gouon-Evans
V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C,
Lisanti MP, Pestell RG and Scherer PE: Adipocyte-secreted factors
synergistically promote mammary tumorigenesis through induction of
anti-apoptotic transcriptional programs and proto-oncogene
stabilization. Oncogene. 22:6408–6423. 2003. View Article : Google Scholar
|
|
33
|
Celis JE, Moreira JM, Cabezon T, Gromov P,
Friis E, Rank F and Gromova I: Identification of extracellular and
intracellular signaling components of the mammary adipose tissue
and its interstitial fluid in high risk breast cancer patients:
toward dissecting the molecular circuitry of epithelial-adipocyte
stromal cell interactions. Mol Cell Proteomics. 4:492–522. 2005.
View Article : Google Scholar
|
|
34
|
Perera CN, Spalding HS, Mohammed SI and
Camarillo IG: Identification of proteins secreted from leptin
stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Exp Biol Med. 233:708–720. 2008. View Article : Google Scholar : PubMed/NCBI
|
